APO RESEARCH · REPORT
Antibody
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Product & engineering
Understand the product.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Selected research
Market Analysis & Forecast
Global Antibody Market Analysis and Forecast 2026-2032
Market perspective
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
Read the full market overview
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
This report presents an overview of global market for Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Antibody, also provides the sales of main regions and countries. Of the upcoming market potential for Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antibody sales, projected growth trends, production technology, application and end-user industry.
Antibody Segment by Company
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Antibody Segment by Type
IgM
IgG
IgA
Other
Antibody Segment by Application
Therapeutic
Research
Diagnostic
Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Antibody in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Antibody manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- IgM
- IgG
- IgA
- Other
Applications
- Therapeutic
- Research
- Diagnostic
Companies covered
- Roche
- Johnson and Johnson
- Merck
- Novartis
- AbbVie
- Amgen
- Pfizer
- Bayer
- Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- Biogen
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Seattle Genetics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Antibody Market by Type
- 1.2.1 Global Antibody Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 IgM
- 1.2.3 IgG
- 1.2.4 IgA
- 1.2.5 Other
- 1.3 Antibody Market by Application
- 1.3.1 Global Antibody Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Therapeutic
- 1.3.3 Research
- 1.3.4 Diagnostic
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Antibody Market Dynamics
- 2.1 Antibody Industry Trends
- 2.2 Antibody Industry Drivers
- 2.3 Antibody Industry Opportunities and Challenges
- 2.4 Antibody Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Antibody Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Antibody Revenue by Region
- 3.2.1 Global Antibody Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Antibody Revenue by Region (2021-2026)
- 3.2.3 Global Antibody Revenue by Region (2027-2032)
- 3.2.4 Global Antibody Revenue Market Share by Region (2021-2032)
- 3.3 Global Antibody Sales Estimates and Forecasts 2021-2032
- 3.4 Global Antibody Sales by Region
- 3.4.1 Global Antibody Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Antibody Sales by Region (2021-2026)
- 3.4.3 Global Antibody Sales by Region (2027-2032)
- 3.4.4 Global Antibody Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Antibody Revenue by Manufacturers
- 4.1.1 Global Antibody Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Antibody Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Antibody Sales by Manufacturers
- 4.2.1 Global Antibody Sales by Manufacturers (2021-2026)
- 4.2.2 Global Antibody Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Antibody Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Antibody Sales Price by Manufacturers (2021-2026)
- 4.4 Global Antibody Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Antibody Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Antibody Manufacturers, Product Type & Application
- 4.7 Global Antibody Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Antibody Market CR5 and HHI
- 4.8.2 2025 Antibody Tier 1, Tier 2, and Tier 3
5 Antibody Market by Type
- 5.1 Global Antibody Revenue by Type
- 5.1.1 Global Antibody Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Antibody Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Antibody Revenue Market Share by Type (2021-2032)
- 5.2 Global Antibody Sales by Type
- 5.2.1 Global Antibody Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Antibody Sales by Type (2021-2032) & (KG)
- 5.2.3 Global Antibody Sales Market Share by Type (2021-2032)
- 5.3 Global Antibody Price by Type
6 Antibody Market by Application
- 6.1 Global Antibody Revenue by Application
- 6.1.1 Global Antibody Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Antibody Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Antibody Revenue Market Share by Application (2021-2032)
- 6.2 Global Antibody Sales by Application
- 6.2.1 Global Antibody Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Antibody Sales by Application (2021-2032) & (KG)
- 6.2.3 Global Antibody Sales Market Share by Application (2021-2032)
- 6.3 Global Antibody Price by Application
7 Company Profiles
- 7.1 Roche
- 7.1.1 Roche Company Information
- 7.1.2 Roche Business Overview
- 7.1.3 Roche Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Roche Antibody Product Portfolio
- 7.1.5 Roche Recent Developments
- 7.2 Johnson and Johnson
- 7.2.1 Johnson and Johnson Company Information
- 7.2.2 Johnson and Johnson Business Overview
- 7.2.3 Johnson and Johnson Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Johnson and Johnson Antibody Product Portfolio
- 7.2.5 Johnson and Johnson Recent Developments
- 7.3 Merck
- 7.3.1 Merck Company Information
- 7.3.2 Merck Business Overview
- 7.3.3 Merck Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Merck Antibody Product Portfolio
- 7.3.5 Merck Recent Developments
- 7.4 Novartis
- 7.4.1 Novartis Company Information
- 7.4.2 Novartis Business Overview
- 7.4.3 Novartis Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Novartis Antibody Product Portfolio
- 7.4.5 Novartis Recent Developments
- 7.5 AbbVie
- 7.5.1 AbbVie Company Information
- 7.5.2 AbbVie Business Overview
- 7.5.3 AbbVie Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 AbbVie Antibody Product Portfolio
- 7.5.5 AbbVie Recent Developments
- 7.6 Amgen
- 7.6.1 Amgen Company Information
- 7.6.2 Amgen Business Overview
- 7.6.3 Amgen Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Amgen Antibody Product Portfolio
- 7.6.5 Amgen Recent Developments
- 7.7 Pfizer
- 7.7.1 Pfizer Company Information
- 7.7.2 Pfizer Business Overview
- 7.7.3 Pfizer Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Pfizer Antibody Product Portfolio
- 7.7.5 Pfizer Recent Developments
- 7.8 Bayer
- 7.8.1 Bayer Company Information
- 7.8.2 Bayer Business Overview
- 7.8.3 Bayer Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Bayer Antibody Product Portfolio
- 7.8.5 Bayer Recent Developments
- 7.9 Lilly
- 7.9.1 Lilly Company Information
- 7.9.2 Lilly Business Overview
- 7.9.3 Lilly Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Lilly Antibody Product Portfolio
- 7.9.5 Lilly Recent Developments
- 7.10 Bristol-Myers Squibb
- 7.10.1 Bristol-Myers Squibb Company Information
- 7.10.2 Bristol-Myers Squibb Business Overview
- 7.10.3 Bristol-Myers Squibb Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Bristol-Myers Squibb Antibody Product Portfolio
- 7.10.5 Bristol-Myers Squibb Recent Developments
- 7.11 GlaxoSmithKline
- 7.11.1 GlaxoSmithKline Company Information
- 7.11.2 GlaxoSmithKline Business Overview
- 7.11.3 GlaxoSmithKline Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 GlaxoSmithKline Antibody Product Portfolio
- 7.11.5 GlaxoSmithKline Recent Developments
- 7.12 Biogen
- 7.12.1 Biogen Company Information
- 7.12.2 Biogen Business Overview
- 7.12.3 Biogen Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Biogen Antibody Product Portfolio
- 7.12.5 Biogen Recent Developments
- 7.13 AstraZeneca
- 7.13.1 AstraZeneca Company Information
- 7.13.2 AstraZeneca Business Overview
- 7.13.3 AstraZeneca Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 AstraZeneca Antibody Product Portfolio
- 7.13.5 AstraZeneca Recent Developments
- 7.14 Sanofi
- 7.14.1 Sanofi Company Information
- 7.14.2 Sanofi Business Overview
- 7.14.3 Sanofi Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Sanofi Antibody Product Portfolio
- 7.14.5 Sanofi Recent Developments
- 7.15 Alexion Pharmaceuticals
- 7.15.1 Alexion Pharmaceuticals Company Information
- 7.15.2 Alexion Pharmaceuticals Business Overview
- 7.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Alexion Pharmaceuticals Antibody Product Portfolio
- 7.15.5 Alexion Pharmaceuticals Recent Developments
- 7.16 Seattle Genetics
- 7.16.1 Seattle Genetics Company Information
- 7.16.2 Seattle Genetics Business Overview
- 7.16.3 Seattle Genetics Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.16.4 Seattle Genetics Antibody Product Portfolio
- 7.16.5 Seattle Genetics Recent Developments
8 North America
- 8.1 North America Antibody Market Size by Type
- 8.1.1 North America Antibody Revenue by Type (2021-2032)
- 8.1.2 North America Antibody Sales by Type (2021-2032)
- 8.1.3 North America Antibody Price by Type (2021-2032)
- 8.2 North America Antibody Market Size by Application
- 8.2.1 North America Antibody Revenue by Application (2021-2032)
- 8.2.2 North America Antibody Sales by Application (2021-2032)
- 8.2.3 North America Antibody Price by Application (2021-2032)
- 8.3 North America Antibody Market Size by Country
- 8.3.1 North America Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Antibody Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Antibody Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Antibody Market Size by Type
- 9.1.1 Europe Antibody Revenue by Type (2021-2032)
- 9.1.2 Europe Antibody Sales by Type (2021-2032)
- 9.1.3 Europe Antibody Price by Type (2021-2032)
- 9.2 Europe Antibody Market Size by Application
- 9.2.1 Europe Antibody Revenue by Application (2021-2032)
- 9.2.2 Europe Antibody Sales by Application (2021-2032)
- 9.2.3 Europe Antibody Price by Application (2021-2032)
- 9.3 Europe Antibody Market Size by Country
- 9.3.1 Europe Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Antibody Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Antibody Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Antibody Market Size by Type
- 10.1.1 China Antibody Revenue by Type (2021-2032)
- 10.1.2 China Antibody Sales by Type (2021-2032)
- 10.1.3 China Antibody Price by Type (2021-2032)
- 10.2 China Antibody Market Size by Application
- 10.2.1 China Antibody Revenue by Application (2021-2032)
- 10.2.2 China Antibody Sales by Application (2021-2032)
- 10.2.3 China Antibody Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Antibody Market Size by Type
- 11.1.1 Asia Antibody Revenue by Type (2021-2032)
- 11.1.2 Asia Antibody Sales by Type (2021-2032)
- 11.1.3 Asia Antibody Price by Type (2021-2032)
- 11.2 Asia Antibody Market Size by Application
- 11.2.1 Asia Antibody Revenue by Application (2021-2032)
- 11.2.2 Asia Antibody Sales by Application (2021-2032)
- 11.2.3 Asia Antibody Price by Application (2021-2032)
- 11.3 Asia Antibody Market Size by Country
- 11.3.1 Asia Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Antibody Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Antibody Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Antibody Market Size by Type
- 12.1.1 SAMEA Antibody Revenue by Type (2021-2032)
- 12.1.2 SAMEA Antibody Sales by Type (2021-2032)
- 12.1.3 SAMEA Antibody Price by Type (2021-2032)
- 12.2 SAMEA Antibody Market Size by Application
- 12.2.1 SAMEA Antibody Revenue by Application (2021-2032)
- 12.2.2 SAMEA Antibody Sales by Application (2021-2032)
- 12.2.3 SAMEA Antibody Price by Application (2021-2032)
- 12.3 SAMEA Antibody Market Size by Country
- 12.3.1 SAMEA Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Antibody Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Antibody Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Antibody Value Chain Analysis
- 13.1.1 Antibody Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Antibody Production Mode & Process
- 13.2 Antibody Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Antibody Distributors
- 13.2.3 Antibody Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst